Scenic Biotech
Series AAmsterdam, NetherlandsMar 2022
Scenic Biotech raised €28M in a Series A round in Mar 2022. The company is based in Amsterdam, Netherlands. Investors in the round: BioGeneration Ventures, BioMedPartners, EIR Ventures and 4 others. Data as of Nov 2026.
Amount raised
€28M
€28,000,000
Native amount
28,000,000 EUR
Stage
Series A
series a
Investors
7
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €28M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedBioGeneration VenturesBioMedPartnersEIR VenturesINKEF CapitalNordic Life ScienceOxford Science EnterprisesVesalius Biocapital Partners
Date
Mar 2022
Round type
series a
Amount (EUR)
€28M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Amsterdam’s Scenic Biotech raises €28M to specialise in evolution-inspired medicine for rare diseasessiliconcanals.com · 2022-03